Precision Medicine Market size worth $87.7bn by 2023 - PowerPoint PPT Presentation

Loading...

PPT – Precision Medicine Market size worth $87.7bn by 2023 PowerPoint presentation | free to download - id: 82b9b4-NWYwM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Precision Medicine Market size worth $87.7bn by 2023

Description:

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. – PowerPoint PPT presentation

Number of Views:69

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Precision Medicine Market size worth $87.7bn by 2023


1
Precision Medicine Market size worth 87.7bn by
2023
2
Global Market Scenario of Precision Medicine
  • Precision Medicine Market size was over USD 39
    billion in 2015, and is anticipated to grow at
    10.5 CAGR from 2016 to 2023.
  • Increasing demand for personalized medicine
    specifically in cancer treatments and
    advancements in new healthcare technologies will
    drive precision global medicine market size.
  • The Favorable government regulations and
    standards will help sustain revenue growth. 
  • Recent research advances have helped expand
    benefits to various aspects of healthcare by
    enabling better understanding of disease
    mechanisms, assessment of disease risks and
    prediction of optimal therapy.
  • A large number of investments in diagnostic
    research will further accelerate the shift from
    treatment to preventive medicine in healthcare.
  • https//www.gminsights.com/industry-analysis/preci
    sion-medicine-market

3
Continue.....
  • The individualized diagnosis approach has
    dramatically improved owing to large-scale
    biologic database development, efficient methods
    for patient characterization, and computational
    tools to analyze large data sets.
  • Emphasizing the need for public health database,
    The White House dedicated USD 55 million for
    creation of its largest database Precision
    Medicine Initiative (PMI). 
  • Precision medicine is a novel method for
    treatment and prevention of chronic diseases
    based on the variability in individual genes and
    other lifestyle characteristics.
  • The new approach enables doctors to better assess
    disease risk, and predict the optimal therapy.
  • President Barack Obama announced the Precision
    Medicine Initiative (PMI) in 2015 to
    revolutionize the concept of medicine and
    generate scientific evidence required for the
    development of precision medicine.
  • US FDA would receive USD 10 million as a part of
    the initiative for building the database to
    support the research and regulation.
  • Get more detail _at_ https//www.gminsights.com/indus
    try-analysis/precision-medicine-market

4
Europe precision medicine market size, by
application, 2013 - 2023 (USD Million)

https//www.gminsights.com/request-sample/detail/6
71
5
360 Analysis
  • Technology Analysis
  • Drug discovery technology was valued at over USD
    9 billion in 2015, and is estimated to expand at
    8.3 CAGR from 2016 to 2023. Biomarker-directed
    therapies with drugs targeting epidermal growth
    factor receptor (EGFR), anaplastic lymphoma
    kinase (ALK), c-ros oncogene 1 receptor tyrosine
    kinase (ROS1) have accelerated the development of
    novel anticancer drugs.
  • Regional Analysis
  • U.S. precision medicine market share was 65 of
    the North American revenue in 2015, mainly on
    account of favorable regulatory landscape. The
    Presidents budget has allocated USD 215 million
    to NIH, NCI, and FDA for development of novel
    solutions.
  • Competitive Market Share
  • Key industry players contributing to global
    precision medicine market share include Pfizer,
    Roche, Covance, Novartis, Qiagen, Biocrates Life
    Sciences, Teva Pharmaceutical, Nanostring
    Technologies, Laboratory Corporation of America
    Holdings, Tepnel Pharma Services, Intomics,
    Ferrer InCode, Silicon Biosystems, Eagle
    Genomics, Medtronic, and Quest Diagnostics. Roche
    is developing an integrated genomics portfolio
    for next generation sequencing (NGS). 
  • Get more detail _at_ https//www.gminsights.com/indus
    try-analysis/precision-medicine-market


6

Latest Research Report On Precision Medicine
 Market _at_ https//www.gminsights.com/industry-anal
ysis/precision-medicine-market Download Latest
Report PDF _at_ https//www.gminsights.com/request-sa
mple/detail/671
7
Stay In Touch You can visit us at
www.gminsights.com
About PowerShow.com